Study on montmorillonite/insulin/TiO2 hybrid nanocomposite as a new oral drug-delivery system

Materials Science and Engineering C

Volumn 75, Issue , 2017, Pages 822-828

  Kamari, Younes ^a   Ghiaci, Payam ^b   Ghiaci, Mehran ^a  

^a ISFAHAN UNIVERSITY OF TECHNOLOGY   (Iran)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Hybrid nanocomposite; Insulin; Intercalation; Montmorillonite; Oral drug delivery; TiO2

Indexed keywords

CLAY MINERALS; COATINGS; DEIONIZED WATER; INSULIN; INTERCALATION; TITANIUM DIOXIDE;

DRUG ENTRAPMENT; HYBRID NANOCOMPOSITES; MONTMORILLONITE NANOCOMPOSITES; ORAL DRUG DELIVERY; ORAL DRUG DELIVERY SYSTEM; POROUS COATINGS; TITANIUM BUTOXIDE; ZETA POTENTIAL ANALYSIS;

NANOCOMPOSITES;

BENTONITE; INSULIN; NANOCOMPOSITE; TITANIUM; TITANIUM DIOXIDE;

CHEMISTRY; DRUG DELIVERY SYSTEM; ORAL DRUG ADMINISTRATION; PROCEDURES;

ADMINISTRATION, ORAL; BENTONITE; DRUG DELIVERY SYSTEMS; INSULIN; NANOCOMPOSITES; TITANIUM;

EID: 85014138118     PISSN: 09284931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msec.2017.02.115     Document Type: Article

References (34)

1. [1] Whiting, D.R., Guariguata, L., Weil, C., Shaw, J., IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res. Clin. Pract. 94 (2011), 311–321.
2. [2] Chen, M.-C., Sonaje, K., Chen, K.-J., Sung, H.-W., A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery. Biomaterials 32 (2011), 9826–9838.
3. [3] Khan Ghilzai, N.M., New developments in insulin delivery. Drug Dev. Ind. Pharm. 29 (2003), 253–265.
4. [4] Maroni, A., Zema, L., Del Curto, M.D., Foppoli, A., Gazzaniga, A., Oral colon delivery of insulin with the aid of functional adjuvants. Adv. Drug Deliv. Rev. 64 (2012), 540–556.
5. [5] Lim, H.-P., Tey, B.-T., Chan, E.-S., Particle designs for the stabilization and controlled-delivery of protein drugs by biopolymers: a case study on insulin. J. Control. Release 186 (2014), 11–21.
6. [6] Golomb, G., Avramoff, A., Hoffman, A., A new route of drug administration: intrauterine delivery of insulin and calcitonin. Pharm. Res. 10 (1993), 828–833.
7. [7] Bailey, M.M., Gorman, E.M., Munson, E.J., Berkland, C., Pure insulin nanoparticle agglomerates for pulmonary delivery. Langmuir 24 (2008), 13614–13620.
8. [8] Díaz, A., David, A., Pérez, R., González, M.L., Báez, A., Wark, S.E., Zhang, P., Clearfield, A., Colón, J.L., Nanoencapsulation of insulin into zirconium phosphate for oral delivery applications. Biomacromolecules 11 (2010), 2465–2470.
9. [9] Li, P., Tan, A., Prestidge, C.A., Nielsen, H.M., Müllertz, A., Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading. Int. J. Pharm. 477 (2014), 390–398.
10. [10] Mo, R., Jiang, T., Di, J., Tai, W., Gu, Z., Emerging micro- and nanotechnology based synthetic approaches for insulin delivery. Chem. Soc. Rev. 43 (2014), 3595–3629.
11. [11] Sonia, T., Sharma, C.P., An overview of natural polymers for oral insulin delivery. Drug Discov. Today 17 (2012), 784–792.
12. [12] Hosseininasab, S., Pashaei-Asl, R., Khandaghi, A.A., Nasrabadi, H.T., Nejati-Koshki, K., Akbarzadeh, A., Joo, S.W., Hanifehpour, Y., Davaran, S., Synthesis, characterization, and in vitro studies of PLGA–PEG nanoparticles for oral insulin delivery. Chem. Biol. Drug Des. 84 (2014), 307–315.
13. [13] Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., Couvreur, P., Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. Chem. Soc. Rev. 42 (2013), 1147–1235.
14. [14] Sant, S., Tao, S.L., Fisher, O.Z., Xu, Q., Peppas, N.A., Khademhosseini, A., Microfabrication technologies for oral drug delivery. Adv. Drug Deliv. Rev. 64 (2012), 496–507.
15. [15] Smirnova, E., Safenkova, I., Stein-Margolina, V., Shubin, V., Gurvits, B., Can aggregation of insulin govern its fate in the intestine? Implications for oral delivery of the drug. Int. J. Pharm. 471 (2014), 65–68.
16. [16] Takahashi, C., Shirai, T., Fuji, M., Study on intercalation of ionic liquid into montmorillonite and its property evaluation. Mater. Chem. Phys. 135 (2012), 681–686.
17. [17] Joshi, G.V., Kevadiya, B.D., Patel, H.A., Bajaj, H.C., Jasra, R.V., Montmorillonite as a drug delivery system: intercalation and in vitro release of timolol maleate. Int. J. Pharm. 374 (2009), 53–57.
18. 1 as drug carrier. Appl. Clay Sci. 45 (2009), 248–253.
19. [19] Jain, S., Datta, M., Montmorillonite-PLGA nanocomposites as an oral extended drug delivery vehicle for venlafaxine hydrochloride. Appl. Clay Sci. 99 (2014), 42–47.
20. 2 composites with controlled drug-delivery properties. Appl. Surf. Sci. 342 (2015), 26–33.
21. 2 hybrid composite as a controlled drug-delivery system. Microporous Mesoporous Mater. 234 (2016), 361–369.
22. [22] Brunauer, S., Emmett, P.H., Teller, E., Adsorption of gases in multimolecular layers. J. Am. Chem. Soc. 60 (1938), 309–319.
23. [23] Barrett, E.P., Joyner, L.G., Halenda, P.P., The determination of pore volume and area distributions in porous substances. I. Computations from nitrogen isotherms. J. Am. Chem. Soc. 73 (1951), 373–380.
24. [24] Dash, S., Murthy, P.N., Nath, L., Chowdhury, P., Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol. Pharm. 67 (2010), 217–223.
25. [25] Zheng, J., Luan, L., Wang, H., Xi, L., Yao, K., Study on ibuprofen/montmorillonite intercalation composites as drug release system. Appl. Clay Sci. 36 (2007), 297–301.
26. [26] Wu, Q., Li, Z., Hong, H., Yin, K., Tie, L., Adsorption and intercalation of ciprofloxacin on montmorillonite. Appl. Clay Sci. 50 (2010), 204–211.
27. [27] Greenwood, R., Review of the measurement of zeta potentials in concentrated aqueous suspensions using electroacoustics. Adv. Colloid Interf. Sci. 106 (2003), 55–81.
28. [28] Greenwood, R., Kendall, K., Selection of suitable dispersants for aqueous suspensions of zirconia and titania powders using acoustophoresis. J. Eur. Ceram. Soc. 19 (1999), 479–488.
29. [29] Ofokansi, K., Winter, G., Fricker, G., Coester, C., Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery. Eur. J. Pharm. Biopharm. 76 (2010), 1–9.
30. [30] Sarier, N., Onder, E., Ersoy, S., The modification of Na-montmorillonite by salts of fatty acids: an easy intercalation process. Colloids Surf. A Physicochem. Eng. Asp. 371 (2010), 40–49.
31. 2 coating on a palladium heterogeneous nanocatalyst. A new method to improve reusability of a catalyst. Catal. Commun. 84 (2016), 16–20.
32. [32] Leofanti, G., Padovan, M., Tozzola, G., Venturelli, B., Surface area and pore texture of catalysts. Catal. Today 41 (1998), 207–219.
33. [33] Kruk, M., Jaroniec, M., Gas adsorption characterization of ordered organic-inorganic nanocomposite materials. Chem. Mater. 13 (2001), 3169–3183.
34. [34] Albarran, L., López, T., Quintana, P., Chagoya, V., Controlled release of IFC-305 encapsulated in silica nanoparticles for liver cancer synthesized by sol–gel. Colloids Surf. A Physicochem. Eng. Asp. 384 (2011), 131–136.